Cipro Peripheral Neuropathy Lawsuit
A type of fluoroquinolones, antibiotics, Cipro has been useful for quite some time in treating a number of kinds of infections.
Discoveries recently have associated Cipro and two other fluoroquinolones to permanent damage of the nerves, with occurring effects immediately after initial use.
Evidence, to add insult to injury, has been revealed to confirm that the makers of the medications knew of this connection, and downplayed purposely, and attempted to conceal the risk from physicians and patients.
Personal injury attorneys represent patients who experienced peripheral neuropathy while taking the Cipro medicine or medications that are similar.
Attorneys involved with a Cipro peripheral neuropathy lawsuit commits to holding liable pharmaceutical manufacturers for sustained injuries from medications due to consumers.
If you sustained nerve damage subsequent to using Cipro, you can contact an attorney to discuss your legal options, as well as the status of your Cipro peripheral neuropathy lawsuit.
In the treatment of infections, Cipro has been vastly helpful. Many of the infections cannot be treated, otherwise, with antibiotics or penicillin; Cipro is typically prescribed for treatment of pneumonia, bronchitis, urinary tract infections, and respiratory infections.
In tablet form in 1987 it received approval from the FDA; then, by 1991, it received approval to be used intravenously.
Cipro and similar medicines, since then, have generated in profits billions of dollars for large pharmaceutical conglomerates as among the primary medication forms to treat a host of bacterial infections.
It was revealed that using Cipro, Avelox, and Levaquin, despite its usefulness, are not without risks.
Documents were disclosed that confirmed complicity on part of key pharmaceuticals manufacturing these medications in their knowledge as early as the mid-1990s, that a major risk was involved in peripheral neuropathy with the use of specific medications.
The definition of peripheral neuropathy is permanent damage to the nerve, which can cause excruciating pain, and loss in critical motor functions.Failure to Warn by Pharmaceutical Companies
Cited in a Cipro peripheral neuropathy lawsuit, as well as against manufacturers of Avelox and Levaquin, the companies had knowledge of these risks and neglected to communicate them.
The risks were downplayed or hidden, in several instances, so that patients would not have time to think twice about using the medications.
Pharmaceutical companies have the responsibility of making known all adverse effects and major risks. Patients, however, are entitled to recover damages for sustained injuries due to misleading warning labels.
By actively concealing risk information, allegations, additionally, entail the defrauding of patients. Stringent liability for marketing a hazardous product knowingly, as well as negligence due to failure of manufacturers to administer research, and monitor patients to make sure the medications are safe are all considered for filing a legal claim.
Pharmaceutical conglomerates have a history of placing profits before safety and avoiding regulations since the last century give or take; this is why it is crucial to hold them liable for actions of negligence.